Skip to main content

Digital Trends may earn a commission when you buy through links on our site. Why trust us?

The Apple Watch "does too much," says Fitbit CEO

fitbit ceo apple watch complicated news version 1459768198 charge hr 2
Image used with permission by copyright holder
James Park, CEO of Fitbit, thinks the biggest problem with wearables is that they do too much, singling out the Apple Watch as one of the devices he considers too complicated. Park, speaking to The Telegraph, also called out companies for not promoting the benefits of these feature-packed wearables, and doing a poor job of telling you why one should be on your list of cool products to buy.

Although Park says simplicity rules in wearables, it seems more complicated products from the company will come in the future. He says Fitbit sees the potential for smarter wearables, and considers those that integrate with smart home products, provide far more in-depth notifications, or can facilitate payments and prove identity a, “huge opportunity.” These features, along with improved fitness and health tracking technology such as blood pressure monitoring and even genomics, may end up being part of future Fitbit wearables.

Recommended Videos

Calling the Apple Watch and competing Android Wear smartwatches, plus many other smart wearables, overly complicated, echoes comments made by several companies during Mobile World Congress this year. In the absence of any major Android Wear announcements at the show, firms producing wearables that focus on style over features said simplicity was what people wanted, and that there was confusion about how to create and market feature-rich wearables to regular people.

Please enable Javascript to view this content

This has also been Fitbit’s approach, and Park says it knew from the company’s formation in 2007 that, “fitness was the killer app,” for its products. Research quoted by Park shows the company has a 30% share of the wearables market, twice its closest rival. Despite this, the recently launched Blaze smartwatch does encroach on Apple and Android Wear’s territory, and wasn’t well received. Both it and the new Alta wristband have sold more than a million each, the latter doing so in three weeks compared to a month for the Blaze.

Andy Boxall
Andy is a Senior Writer at Digital Trends, where he concentrates on mobile technology, a subject he has written about for…
The Apple Watch Series 10 has ruined smartwatches for me
A person wearing the aluminum Apple Watch Series 10.

That’s it, the Apple Watch Series 10 has ruined other smartwatches for me. This week I will swap to another smartwatch I have to review, but I don’t want to take the Apple Watch off. It's wonderful.

I don’t want to use the word perfect because, of course, it’s not, but it’s very, very close to it. Prepare for some gushing over the next few hundred words, as I’m going to explain why if you’re looking for a smartwatch, the search can stop with the Apple Watch Series 10.
Why don’t I want to take it off?

Read more
I already damaged my Apple Watch Series 10
i already damaged my apple watch series 10 dt 1

I don’t think I’m clumsy, but I swing my arms a lot and still grimace every time a smartwatch on my wrist hits an immovable object. Yet, for all this movement, I’ve never managed to deeply scratch or lightly crack an Apple Watch display … until now.

The Apple Watch Series 10 doesn’t have many compromises over the Apple Watch Ultra 2, and I even made the switch permanently before this happened. It’s big, thin, and beautiful, but the Apple Watch Series 10 also uses a less durable protective shield for its display.

Read more
Blood oxygen tracking isn’t coming back to the Apple Watch anytime soon
Apple Watch Ultra taking a measurement for blood oxygen levels.

One of the major selling points of Apple Watches in recent years has been the ability to test users’ blood oxygen levels. Unfortunately, ongoing litigation has prevented this feature from being included in Apple Watches sold in the U.S. since January. Now, it seems unlikely that this situation will change soon.

On Friday, a Delaware jury found that health-monitoring technology company Masimo infringed on some of Apple’s earlier smartwatch patents. As a result, Apple received an award of only $250. However, the same jury ruled that Masimo's current watches did not infringe on the patents that Apple accused it of copying. Consequently, an injunction remains in effect in the U.S. that prevents the company from offering blood oxygen tracking on new watches sold in the country.

Read more